Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Perry

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Cancer Research|August 19, 2015
A Quantitative System for Studying Metastasis Using Transparent ZebrafishSilja Heilmann, Kajan Ratnakumar, Erin Langdon, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Loss of the Coronary Artery Disease Risk Gene <i>Leiomodin1</i> in Vascular Smooth Muscle Cells Triggers Rapid Onset Coronary AtherosclerosisAmr R Salem, Jaser Doja, Chunyu Ge, et al.
Leukemia|November 14, 2022
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemiaSteven Sher, Ethan Whipp, Janek Walker, et al.
Rheumatology Advances in Practice|May 20, 2024
The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scopeJennifer Hannah, Mia Rodziewicz, Puja Mehta, et al.
Inflammatory Bowel Diseases|November 24, 2025
CAPTURE IBD: Advancing Precision Medicine in Pediatric IBDShova Subedi, Lindsey G Albenbergl, Julie A Bass, et al.
Haematologica|August 8, 2024
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemiaJanani Ravikrishnan, Daisy Y Diaz-Rohena, Elizabeth Muhowski, et al.
Blood Cancer Discovery|November 5, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic LeukemiaBritten K Gordon, Elizabeth M Muhowski, Jyotsana Singh, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Cancer Research|August 19, 2015
A Quantitative System for Studying Metastasis Using Transparent ZebrafishSilja Heilmann, Kajan Ratnakumar, Erin Langdon, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Loss of the Coronary Artery Disease Risk Gene <i>Leiomodin1</i> in Vascular Smooth Muscle Cells Triggers Rapid Onset Coronary AtherosclerosisAmr R Salem, Jaser Doja, Chunyu Ge, et al.
Leukemia|November 14, 2022
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemiaSteven Sher, Ethan Whipp, Janek Walker, et al.
Rheumatology Advances in Practice|May 20, 2024
The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scopeJennifer Hannah, Mia Rodziewicz, Puja Mehta, et al.
Inflammatory Bowel Diseases|November 24, 2025
CAPTURE IBD: Advancing Precision Medicine in Pediatric IBDShova Subedi, Lindsey G Albenbergl, Julie A Bass, et al.
Haematologica|August 8, 2024
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemiaJanani Ravikrishnan, Daisy Y Diaz-Rohena, Elizabeth Muhowski, et al.
Blood Cancer Discovery|November 5, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic LeukemiaBritten K Gordon, Elizabeth M Muhowski, Jyotsana Singh, et al.
Pageof 6